Pure Global AI
ANVISA registration 80134860315Valid until Jun 30, 2035

IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN

ANVISA Registration Number: 80134860315GRIFOLS BRASIL LTDAPROGENIKA BIOPHARMA S.L.Risk Class IV
Verified
Device names
Technical name
IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
View exact technical-name matches →
PT: IMUNOHEMATOLOGIA - RH-HR, KELL, KIDD, DUFFY - ORIGEM MONOCLONAL
Commercial name
ID CORE CONTROL
View exact commercial-name matches →
Risk class
Class IV
Registration details
Registration Number
80134860315
Process Number
25351389138202473
CNPJ
02513899000171
Company information
Registration Holder
GRIFOLS BRASIL LTDA
Manufacturer
PROGENIKA BIOPHARMA S.L.
Manufacturing Country
Spain
PT: ESPANHA
Dates and status
Publication Date
Jun 30, 2025
Validity
30/06/2035
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80134860315 and manufactured by PROGENIKA BIOPHARMA S.L.. The registration is held by GRIFOLS BRASIL LTDA with validity until Jun 30, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.